THC Therapeutics Income Statement

Financials in millions USD. Fiscal year is August - July.

Millions USD. Fiscal year is Aug - Jul.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2016
Period Ending	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021	Jul '20 Jul 31, 2020	2019 - 2016
Selling, General & Admin	0.54	0.49	1.75	0.94	1.39	Upgrade
Operating Expenses	0.54	0.49	1.75	0.94	1.39	Upgrade
Operating Income	-0.54	-0.49	-1.75	-0.94	-1.39	Upgrade
Interest Expense	-0.14	-0.08	-0.1	-0.55	-0.49	Upgrade
Other Non Operating Income (Expenses)	-0.13	0.18	0.33	-0.39	0.12	Upgrade
EBT Excluding Unusual Items	-0.81	-0.39	-1.52	-1.89	-1.75	Upgrade
Gain (Loss) on Sale of Investments	-	-	-	-	-0.01	Upgrade
Other Unusual Items	-	0	-	-	-0.17	Upgrade
Pretax Income	-0.81	-0.39	-1.52	-1.89	-1.93	Upgrade
Net Income	-0.81	-0.39	-1.52	-1.89	-1.93	Upgrade
Net Income to Common	-0.81	-0.39	-1.52	-1.89	-1.93	Upgrade
Shares Outstanding (Basic)	36	33	33	24	17	Upgrade
Shares Outstanding (Diluted)	36	33	33	24	17	Upgrade
Shares Change (YoY)	8.76%	-1.32%	40.51%	42.95%	23.73%	Upgrade
EPS (Basic)	-0.02	-0.01	-0.05	-0.08	-0.12	Upgrade
EPS (Diluted)	-0.02	-0.01	-0.05	-0.08	-0.12	Upgrade
Free Cash Flow	-0.18	-0.09	-0.42	-0.39	-0.59	Upgrade
Free Cash Flow Per Share	-0.01	-0.00	-0.01	-0.02	-0.04	Upgrade
EBITDA	-0.54	-0.49	-1.73	-0.92	-1.37	Upgrade
D&A For EBITDA	0	0	0.01	0.02	0.02	Upgrade
EBIT	-0.54	-0.49	-1.75	-0.94	-1.39	Upgrade
Advertising Expenses	-	-	-	0.03	0.05	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.